Back to Results
First PageMeta Content
Pharmacology / Oxfam / Médecins Sans Frontières / Gilead Sciences / European Union / Peace / Campaign for Access to Essential Medicines / European Federation of Pharmaceutical Industries and Associations / Pharmacy / Pharmaceutical sciences / Pharmaceutical industry


PRESS RELEASE 24 September, 2014 Embargoed until 00:01am CET Monday, 29 September, 2014 New Oxfam–HAI Europe report
Add to Reading List

Document Date: 2014-09-24 09:28:24

Open Document

File Size: 289,36 KB

Share Result on Facebook

City

Washington / DC / /

Company

Investment Partnership / Gilead Sciences / Transatlantic Trade / HAI Europe / /

Continent

Europe / /

Country

Thailand / United States / India / /

Currency

USD / EUR / /

/

Event

Business Partnership / /

IndustryTerm

profit-driven pharmaceutical industry / pharmaceutical industry / Fragile health systems / pharmaceutical innovation models / pharmaceutical manufacturers / pharmaceutical products / hepatitis C treatment / /

MedicalCondition

hepatitis C. About / cancer / disease / Ebola / Ebola virus disease / hepatitis C / widely accessible Ebola / diseases / another hepatitis C / HIV/AIDS / /

Organization

World Health Organization / Oxfam / German Foundation for World Population / European Commission / European Union / European Parliament / UNAIDS / /

Person

Aliénor Devalière / Leïla Bodeux / Cecilia Malmström / /

/

Position

EDITOR / policy advisor / Commissioner / nominated European Trade Commissioner / /

Region

West Africa / /

Technology

Drug Discovery / /

URL

www.haieurope.org / /

SocialTag